$109.93
-3.67-3.23%
Últ. Act.: Nov 6, 5:29 PM
Abbott Laboratories (ABT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 21, 2026 | $1.42 | $1.42 | 0.00 % |
| Q2 | Jul 16, 2026 | $1.31 | $1.28 | 2.34 % |
| Q1 | Apr 16, 2026 | $1.15 | $1.14 | 0.88 % |
| Q4 | Jan 22, 2026 | $1.50 | $1.50 | 0.00 % |
Quarterly Revenue (Billions)
Abbott Laboratories (ABT) emitió su última guía sobre octubre 21, 2026 para Q4 2026. La compañía estimó unas ganancias por acción en el rango de $1.62 - $1.67, en comparación con una estimación de consenso de EPS de $1.64.
En comparación con la previsión anterior, Abbott Laboratories reducido redujo su previsión de BPA desde un rango anterior de $5.5 - $5.55.
Abbott Laboratories ha emitido 27 actualizaciones de orientación entre el enero 25, 2023 y el octubre 21, 2026. During this period, the company raised its outlook 5 times and lowered it 10 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.42 | $1.28 | $1.14 | $1.50 |
| Actual | $1.42 | $1.31 | $1.15 | $1.50 |
| Surprise | 0.00% | +2.34% | +0.88% | 0.00% |
| Revenue | ||||
| Estimate | $12.99B | $12.51B | $11.01B | $11.80B |
| Actual | $13.01B | $12.59B | $11.16B | $11.46B |
| Surprise | +0.21% | +0.66% | +1.43% | -2.87% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.64 | $1.23 | $1.44 | $1.54 |
| Revenue | ||||
| Consensus | $13.21B | $12.57B | — | — |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 21, 2026 | $13.01B | $12.99B | 0.21 % |
| Q2 | Jul 16, 2026 | $12.59B | $12.51B | 0.66 % |
| Q1 | Apr 16, 2026 | $11.16B | $11.01B | 1.43 % |
| Q4 | Jan 22, 2026 | $11.46B | $11.80B | -2.87 % |